Bruno M.D.C. Godinho - Related publications
Affiliations: | University Of Massachusetts Med Sch Worcester |
Area:
RNA Therapeutics, siRNA, Oligonucleotide Delivery, CNS
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
50 most relevant papers in past 60 days:
Year | Citation | Score | |
---|---|---|---|
2021 | Zantye P, Shende S, Ramanan SR, Talukdar I, Kowshik M. Design of a Biocompatible Hydroxyapatite-Based Nanovehicle for Efficient Delivery of Small Interference Ribonucleic Acid into Mouse Embryonic Stem Cells. Molecular Pharmaceutics. PMID 33464088 DOI: 10.1021/acs.molpharmaceut.0c00684 | ||
2021 | Verma P, Srivastava A, Srikanth CV, Bajaj A. Nanoparticle-mediated gene therapy strategies for mitigating inflammatory bowel disease. Biomaterials Science. PMID 33404019 DOI: 10.1039/d0bm01359e | ||
2021 | Li F, Xu X, Liang Y, Li Y, Wang M, Zhao F, Wang X, Sun Y, Chen W. Nuclear-targeted nanocarriers based on pH-sensitive amphiphiles for enhanced GNA002 delivery and chemotherapy. Nanoscale. PMID 33576757 DOI: 10.1039/d0nr07239g | ||
2021 | Liu Y, Castro Bravo KM, Liu J. Targeted liposomal drug delivery: a nanoscience and biophysical perspective. Nanoscale Horizons. PMID 33400747 DOI: 10.1039/d0nh00605j | ||
2021 | Lu X, Zhang Y, Wang L, Li G, Gao J, Wang Y. Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment. Drug Delivery. 28: 380-389. PMID 33586561 DOI: 10.1080/10717544.2021.1883158 | ||
2021 | Munson MJ, O'Driscoll G, Silva AM, Lázaro-Ibáñez E, Gallud A, Wilson JT, Collén A, Esbjörner EK, Sabirsh A. A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery. Communications Biology. 4: 211. PMID 33594247 DOI: 10.1038/s42003-021-01728-8 | ||
2021 | Zhou Z, Sun T, Jiang C. Recent advances on drug delivery nanocarriers for cerebral disorders. Biomedical Materials (Bristol, England). PMID 33455956 DOI: 10.1088/1748-605X/abdc97 | ||
2021 | Lei C, Liu XR, Chen QB, Li Y, Zhou JL, Zhou LY, Zou T. Hyaluronic Acid and Albumin Based Nanoparticles for Drug Delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33503486 DOI: 10.1016/j.jconrel.2021.01.033 | ||
2021 | Su S, Cao S, Liu J, Xu X. Mitochondria-specific delivery system for targeted regulation of mitochondrial gene expression. Star Protocols. 2: 100275. PMID 33511358 DOI: 10.1016/j.xpro.2020.100275 | ||
2021 | Hsu JF, Chu SM, Liao CC, Wang CJ, Wang YS, Lai MY, Wang HC, Huang HR, Tsai MH. Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update. Cancers. 13. PMID 33430494 DOI: 10.3390/cancers13020195 | ||
2021 | Pradhan D, Biswasroy P, Goyal A, Ghosh G, Rath G. Recent Advancement in Nanotechnology-Based Drug Delivery System Against Viral Infections. Aaps Pharmscitech. 22: 47. PMID 33447909 DOI: 10.1208/s12249-020-01908-5 | ||
2021 | Bao J, Zhang Q, Duan T, Hu R, Tang J. The fate of nanoparticles in vivo and the strategy of designing stealth nanoparticle for drug delivery. Current Drug Targets. PMID 33461465 DOI: 10.2174/1389450122666210118105122 | ||
2021 | Khiev D, Mohamed ZA, Vichare R, Paulson R, Bhatia S, Mohapatra S, Lobo GP, Valapala M, Kerur N, Passaglia CL, Mohapatra SS, Biswal MR. Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery. Nanomaterials (Basel, Switzerland). 11. PMID 33445545 DOI: 10.3390/nano11010173 | ||
2021 | Kumar A, Bhattacharya S, Singh C, Sharma V. Poly (lactic-co-glycolic acid) & tocopheryl polyethylene glycol succinate nanoparticles for the treatment of different brain cancer. Anti-Cancer Agents in Medicinal Chemistry. PMID 33563201 DOI: 10.2174/1871520621666210204201347 | ||
2021 | Pędziwiatr-Werbicka E, Gorzkiewicz M, Horodecka K, Lach D, Barrios-Gumiel A, Sánchez-Nieves J, Gómez R, de la Mata FJ, Bryszewska M. PEGylation of Dendronized Gold Nanoparticles Affects Their Interaction with Thrombin and siRNA. The Journal of Physical Chemistry. B. PMID 33481607 DOI: 10.1021/acs.jpcb.0c10177 | ||
2021 | de Menezes BRC, Rodrigues KF, Schatkoski VM, Pereira RM, Ribas RG, Montanheiro TLDA, Thim GP. Current advances in drug delivery of nanoparticles for respiratory disease treatment. Journal of Materials Chemistry. B. PMID 33508058 DOI: 10.1039/d0tb01783c | ||
2021 | Jhaveri J, Raichura Z, Khan T, Momin M, Omri A. Chitosan Nanoparticles-Insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics. Molecules (Basel, Switzerland). 26. PMID 33430478 DOI: 10.3390/molecules26020272 | ||
2021 | Rojas-Prats E, Tosat-Bitrián C, Martínez-González L, Nozal V, Pérez DI, Martínez A. Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles. Pharmaceutics. 13. PMID 33525757 DOI: 10.3390/pharmaceutics13020180 | ||
2021 | Vasey CE, Cavanagh RJ, Taresco V, Moloney C, Smith S, Rahman R, Alexander C. Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations. Pharmaceutics. 13. PMID 33546301 DOI: 10.3390/pharmaceutics13020208 | ||
2021 | Kaur I, Kumar A, Behl T, Setia D. Recent Advances in Nanotechnology-Based Drug Delivery Approaches for Alzheimer disease. Current Drug Targets. PMID 33397264 DOI: 10.2174/1389450122999210104205018 | ||
2021 | Wang Y, Zhang K, Li T, Maruf A, Qin X, Luo L, Zhong Y, Qiu J, McGinty S, Pontrelli G, Liao X, Wu W, Wang G. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics. 11: 164-180. PMID 33391468 DOI: 10.7150/thno.47841 | ||
2021 | Wei C, Wang P, Huang Z, He D, Zhu W, Liu H, Chen Z, Wang W, Li Y, Shen J, Qin L. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy. Molecular Pharmaceutics. PMID 33530691 DOI: 10.1021/acs.molpharmaceut.0c01164 | ||
2021 | Birolini G, Valenza M, Ottonelli I, Passoni A, Favagrossa M, Duskey JT, Bombaci M, Vandelli MA, Colombo L, Bagnati R, Caccia C, Leoni V, Taroni F, Forni F, Ruozi B, et al. Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33412229 DOI: 10.1016/j.jconrel.2020.12.051 | ||
2021 | Eroglu E. A Resveratrol-Loaded Poly(2-hydroxyethyl methacrylate)-Chitosan Based Nanotherapeutic: Characterization and Cytotoxicity Against Prostate Cancer. Journal of Nanoscience and Nanotechnology. 21: 2090-2098. PMID 33500023 DOI: 10.1166/jnn.2021.19317 | ||
2021 | Wang Y, Xie H, Ying K, Xie B, Chen X, Yang B, Jin J, Wan J, Li T, Han W, Fang S, Wang H. Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies. Biomaterials. 270: 120705. PMID 33581609 DOI: 10.1016/j.biomaterials.2021.120705 | ||
2021 | Gagliardi A, Giuliano E, Venkateswararao E, Fresta M, Bulotta S, Awasthi V, Cosco D. Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors. Frontiers in Pharmacology. 12: 601626. PMID 33613290 DOI: 10.3389/fphar.2021.601626 | ||
2021 | Tabbasam R, Khursid S, Ishaq Y, Malik A. In vivo evaluation of inorganic nanoparticle complexes against CCL4 induced hepatotoxicity. Current Drug Delivery. PMID 33530908 DOI: 10.2174/1567201818666210202105531 | ||
2021 | Sonkar R, Sonali, Jha A, Viswanadh MK, Burande AS, Narendra, Pawde DM, Patel KK, Singh M, Koch B, Muthu MS. Gold liposomes for brain-targeted drug delivery: Formulation and brain distribution kinetics. Materials Science & Engineering. C, Materials For Biological Applications. 120: 111652. PMID 33545820 DOI: 10.1016/j.msec.2020.111652 | ||
2021 | Sha X, Dai Y, Song X, Liu S, Zhang S, Li J. The Opportunities and Challenges of Silica Nanomaterial for Atherosclerosis. International Journal of Nanomedicine. 16: 701-714. PMID 33536755 DOI: 10.2147/IJN.S290537 | ||
2021 | Mo Y, Duan L, Yang Y, Liu W, Zhang Y, Zhou L, Su S, Lo PC, Cai J, Gao L, Liu Q, Chen X, Yang C, Wang Q, Chen T. Nanoparticles improved resveratrol brain delivery and its therapeutic efficacy against intracerebral hemorrhage. Nanoscale. PMID 33565555 DOI: 10.1039/d0nr06249a | ||
2021 | Rai S, Singh N, Bhattacharya S. Concepts on Smart Nano-Based Drug Delivery System. Recent Patents On Nanotechnology. PMID 33494685 DOI: 10.2174/1872210515666210120113738 | ||
2021 | Piscatelli JA, Ban J, Lucas AT, Zamboni WC. Complex Factors and Challenges that Affect the Pharmacology, Safety and Efficacy of Nanocarrier Drug Delivery Systems. Pharmaceutics. 13. PMID 33477395 DOI: 10.3390/pharmaceutics13010114 | ||
2021 | Wang T, Li P, Wan T, Tu B, Li J, Huang F. TIGIT/PVR and LncRNA ANRIL Dual-targetable PAMAM Polymeric Nanoparticles Efficiently Inhibited the Hepatoma Carcinoma by Combination of Immunotherapy and Gene Therapy. Journal of Drug Targeting. 1-22. PMID 33480288 DOI: 10.1080/1061186X.2021.1879088 | ||
2021 | Chen H, Chen H, Wang Y, Bai Y, Yuan P, Che Z, Zhang L. A novel self-coated polydopamine nanoparticle for synergistic photothermal-chemotherapy. Colloids and Surfaces. B, Biointerfaces. 200: 111596. PMID 33582445 DOI: 10.1016/j.colsurfb.2021.111596 | ||
2021 | Chen C, Sun M, Liu X, Wu W, Su L, Li Y, Liu G, Yan X. General and mild modification of food-derived extracellular vesicles for enhanced cell targeting. Nanoscale. PMID 33521806 DOI: 10.1039/d0nr06309f | ||
2021 | Delshadi R, Bahrami A, Mcclements DJ, Moore MD, Williams L. Development of nanoparticle-delivery systems for antiviral agents: A review. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33450319 DOI: 10.1016/j.jconrel.2021.01.017 | ||
2021 | Dutta K, Das R, Medeiros J, Thayumanavan S. Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery. Biochemistry. PMID 33428850 DOI: 10.1021/acs.biochem.0c00860 | ||
2021 | Das S, Imlimthan S, Airaksinen AJ, Sarparanta M. Radiolabeling of Theranostic Nanosystems. Advances in Experimental Medicine and Biology. 1295: 49-76. PMID 33543455 DOI: 10.1007/978-3-030-58174-9_3 | ||
2021 | He Y, Lei L, Cao J, Yang X, Cai S, Tong F, Huang D, Mei H, Luo K, Gao H, He B, Peppas NA. A combinational chemo-immune therapy using an enzyme-sensitive nanoplatform for dual-drug delivery to specific sites by cascade targeting. Science Advances. 7. PMID 33547067 DOI: 10.1126/sciadv.aba0776 | ||
2021 | Chen CC, Baikoghli MA, Cheng RH. Protein-based nanoplatform for detection of tumorigenic polyps in the colon via noninvasive mucosal routes. Pharmaceutical Patent Analyst. PMID 33467938 DOI: 10.4155/ppa-2020-0034 | ||
2021 | Zhang Z, Yue YX, Xu L, Wang Y, Geng WC, Li JJ, Kong XL, Zhao X, Zheng Y, Zhao Y, Shi L, Guo DS, Liu Y. Macrocyclic-Amphiphile-Based Self-Assembled Nanoparticles for Ratiometric Delivery of Therapeutic Combinations to Tumors. Advanced Materials (Deerfield Beach, Fla.). e2007719. PMID 33598992 DOI: 10.1002/adma.202007719 | ||
2021 | Gürcan S, Tsapis N, Reynaud F, Denis S, Vergnaud J, Özer Ö, Fattal E. Combining dexamethasone and TNF-α siRNA within the same nanoparticles to enhance anti-inflammatory effect. International Journal of Pharmaceutics. 598: 120381. PMID 33610735 DOI: 10.1016/j.ijpharm.2021.120381 | ||
2021 | Wang R, Sha X. Biomimetic Drug Delivery Systems Oriented by Biological Function in Tumor Targeting. Current Drug Targets. PMID 33459231 DOI: 10.2174/1389450122666210114095859 | ||
2021 | Lockhart JH, VanWye J, Banerjee R, Wickline SA, Pan H, Totary-Jain H. Self-assembled miRNA-switch nanoparticles target denuded regions and prevent restenosis. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33545360 DOI: 10.1016/j.ymthe.2021.01.032 | ||
2021 | Hartl N, Adams F, Merkel OM. From adsorption to covalent bonding: Apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood-brain barrier. Advanced Therapeutics. 4. PMID 33542947 DOI: 10.1002/adtp.202000092 | ||
2021 | Horo H, Bhattacharyya S, Mandal B, Kundu LM. Synthesis of functionalized silk-coated chitosan-gold nanoparticles and microparticles for target-directed delivery of antitumor agents. Carbohydrate Polymers. 258: 117659. PMID 33593545 DOI: 10.1016/j.carbpol.2021.117659 | ||
2021 | Stephen S, Gorain B, Choudhury H, Chatterjee B. Exploring the role of mesoporous silica nanoparticle in the development of novel drug delivery systems. Drug Delivery and Translational Research. PMID 33604837 DOI: 10.1007/s13346-021-00935-4 | ||
2021 | Schoppa T, Jung D, Rust T, Mulac D, Kuckling D, Langer K. Light-responsive polymeric nanoparticles based on a novel nitropiperonal based polyester as drug delivery systems for photosensitizers in PDT. International Journal of Pharmaceutics. 120326. PMID 33540003 DOI: 10.1016/j.ijpharm.2021.120326 | ||
2021 | Luo D, Zhang Y, Wang M, Zhu C, Yao Y, Yao W, Zhang L, Cheng FF. Multifunctional titanium phosphate carriers for enhancing drug delivery and evaluating real-time therapeutic efficacy of a hydrophobic drug component in . The Analyst. PMID 33599635 DOI: 10.1039/d1an00163a | ||
2021 | Phung CD, Tran TH, Choi JY, Jeong JH, Ku SK, Yong CS, Kim JO. Pre- and Post-Transcriptional Regulation of cFLIP for Effective Cancer Therapy Using pH-Ultrasensitive Nanoparticles. Acs Applied Materials & Interfaces. PMID 33506682 DOI: 10.1021/acsami.0c20624 |